Effectdossier · gearchiveerd kwartaal
RXST
RxSight, Inc. · Healthcare · Medical - Devices
14Gevolgde houders
0Δ houders
12.67MGehouden aandelen
$164.75MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +30.0% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -7 | 30.76M | $148.37M | +3 | −9 |
| Q1 2026 | 78 | +10 | 29.02M | $178.70M | +11 | −1 |
| Q4 2025 | 68 | 0 | 28.07M | $292.47M | +1 | −1 |
| Q3 2025 | 17 | 0 | 14.88M | $133.76M | +1 | −1 |
| Q2 2025 | 14 | 0 | 12.67M | $164.75M | +1 | −1 |
| Q1 2025 | 11 | -1 | 4.08M | $103.15M | — | −1 |
| Q4 2024 | 12 | 0 | 5.10M | $175.38M | — | — |
| Q3 2024 | 11 | -1 | 3.15M | $155.64M | — | −1 |
| Q2 2024 | 12 | — | 2.73M | $164.29M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 3.01M | — | $39.09M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 2.28M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passief) | 2.28M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passief) | 2.28M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 2.28M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 2.28M | — | $29.62M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 1.32M | +5906.1% | $17.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 1.32M | +5906.1% | $17.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 1.03M | +346.5% | $13.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 1.03M | +346.5% | $13.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Millennium Management ✦ | 951.18K | +5.9% | $12.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | State Street Global Advisors ✦ (passief) | 916.22K | +1.9% | $11.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 862.67K | -0.1% | $11.22M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Geode Capital Management ✦ (passief) | 862.67K | -0.1% | $11.22M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 30 | Wellington Management ✦ | 727.95K | Nieuw | $9.46M | 0.0% | New | 1 | SEC ↗ |
| 31 | Wellington Management ✦ | 727.95K | Nieuw | $9.46M | 0.0% | New | 1 | SEC ↗ |
| 32 | Wellington Management ✦ | 727.95K | Nieuw | $9.46M | 0.0% | New | 1 | SEC ↗ |
| 33 | Wellington Management ✦ | 727.95K | Nieuw | $9.46M | 0.0% | New | 1 | SEC ↗ |
| 34 | Baillie Gifford ✦ | 468.94K | +19.6% | $6.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Baillie Gifford ✦ | 468.94K | +19.6% | $6.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Baillie Gifford ✦ | 468.94K | +19.6% | $6.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Baillie Gifford ✦ | 468.94K | +19.6% | $6.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Two Sigma Investments ✦ | 440.46K | +270.5% | $5.73M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Renaissance Technologies ✦ | 426.40K | -5.6% | $5.54M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 157.14K | — | $2.04M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 157.14K | — | $2.04M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Fidelity (FMR) ✦ | 157.14K | — | $2.04M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 64.30K | +67.8% | $835,900 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 64.30K | +67.8% | $835,900 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 64.30K | +67.8% | $835,900 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 64.30K | +67.8% | $835,900 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 64.30K | +67.8% | $835,900 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 23.10K | +30.2% | $301,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Wellington Management | $9.46M | 0.0% |
| Wellington Management | $9.46M | 0.0% |
| Wellington Management | $9.46M | 0.0% |
| Wellington Management | $9.46M | 0.0% |
Verlaten
| Point72 Asset Management | $3.89M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 162 houders, 37.72M aandelen, $223.80M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API